Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

BACKGROUND: The cost of schizophrenia in Japan is high and new long-acting injectable (LAI) antipsychotics might be able to reduce costs by causing a reduction of hospital stays. We aim to estimate budget effects of the introduction of a new 1-month LAI, paliperidone palmitate, in Japan. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlich, Jörg, Nishi, Masamichi, Saito, Yoshimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447166/
https://www.ncbi.nlm.nih.gov/pubmed/26045674
http://dx.doi.org/10.2147/CEOR.S85514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447166/
https://www.ncbi.nlm.nih.gov/pubmed/26045674
http://dx.doi.org/10.2147/CEOR.S85514

Ejemplares similares